Abstract
1 The sedative effects in rats of two phenylquinolines, PK 9084 and PK 8165 (5-50 mg/kg), were examined in a holeboard: both when given alone and when given in conjunction with chlordiazepoxide (5 mg/kg). 2 Both phenylquinolines produced significant dose-related decreases in locomotor activity and rearing, with an ED50 about twice that for chlordiazepoxide. 3 When the phenylquinolines were combined with chlordiazepoxide the degree of sedation was equal to that seen with either drug given alone, whichever produced the greater sedation; the sedative effects of the two drugs were never additive. 4 PK 9084 (10 and 50 mg kg) significantly reduced rectal temperature, as did chlordiazepoxide (5 mg/kg), but there was no addition nor interaction of their effects. 5 Both phenylquinolines also reduced exploratory head-dipping, as did chlordiazepoxide, but in combination they antagonized each other's effects. 6 The classification of the phenylquinolines as non-sedative anxiolytics, acting as agonists at the benzodiazepine receptors needs revision.
Full text
PDFSelected References
These references are in PubMed. This may not be the complete list of references from this article.
- Czernik A. J., Petrack B., Kalinsky H. J., Psychoyos S., Cash W. D., Tsai C., Rinehart R. K., Granat F. R., Lovell R. A., Brundish D. E. CGS 8216: receptor binding characteristics of a potent benzodiazepine antagonist. Life Sci. 1982 Jan 25;30(4):363–372. doi: 10.1016/0024-3205(82)90573-2. [DOI] [PubMed] [Google Scholar]
- File S. E., Wardill A. G. Validity of head-dipping as a measure of exploration in a modified hole-board. Psychopharmacologia. 1975 Oct 14;44(1):53–59. doi: 10.1007/BF00421184. [DOI] [PubMed] [Google Scholar]
- Le Fur G., Mizoule J., Burgevin M. C., Ferris O., Heaulme M., Gauthier A., Guérémy C., Uzan A. Multiple benzodiazepine receptors: evidence of dissociation between anticonflict and anticonvulsant properties by PK 8165 and PK 9084 (two quinoline derivatives). Life Sci. 1981 Mar 30;28(13):1439–1448. doi: 10.1016/0024-3205(81)90375-1. [DOI] [PubMed] [Google Scholar]